Cargando…

EPEN-22. SINGLE-CELL RNA SEQUENCING IDENTIFIES UPREGULATION OF IKZF1 IN PFA2 MYELOID SUBPOPULATION DRIVING AN ANTI-TUMOR PHENOTYPE

We have previously shown immune gene phenotype variations between posterior fossa ependymoma subgroups. PFA1 tumors chronically secrete IL-6, which pushes the infiltrating myeloid cells to an immune suppressive function. In contrast, PFA2 tumors have a more immune activated phenotype and have a bett...

Descripción completa

Detalles Bibliográficos
Autores principales:	Griesinger, Andrea, Prince, Eric, Donson, Andrew, Riemondy, Kent, Ritzman, Timothy, Harris, Faith, Amani, Vladimir, Handler, Michael, Hankinson, Todd, Grundy, Richard, Jackson, Andrew, Foreman, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Ependymoma
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715268/ http://dx.doi.org/10.1093/neuonc/noaa222.159

Ejemplares similares

EPEN-26. NON-CANONICAL NF-κB SIGNALING DRIVES MESENCHYMAL EPENDYMAL CELL SUBPOPULATION IN PFA EPENDYMOMA
por: Griesinger, Andrea, et al.
Publicado: (2020)

EPEN-07. SINGLE-CELL RNA SEQUENCING IDENTIFIES A UNIQUE MYELOID SUBPOPULATION ASSOCIATED WITH MESENCHYMAL TUMOR SUBPOPULATION IN POOR OUTCOME PEDIATRIC EPENDYMOMA
por: Griesinger, Andrea, et al.
Publicado: (2021)

EPEN-31. SINGLE-CELL RNAseq OF CHILDHOOD EPENDYMOMA REVEALS DISTINCT NEOPLASTIC CELL SUBPOPULATIONS THAT IMPACT ETIOLOGY, MOLECULAR CLASSIFICATION AND OUTCOME
por: Donson, Andrew, et al.
Publicado: (2020)

EPEN-11. TUMOR DIFFERENTIATION IMPACTS THE BIOLOGY OF RECURRENCE IN CHILDHOOD POSTERIOR FOSSA EPENDYMOMA
por: Donson, Andrew, et al.
Publicado: (2021)

EPEN-08. THE TREM1 POSITIVE HYPOXIC MYELOID SUBPOPULATION IN POSTERIOR FOSSA EPENDYMOMA
por: Willard, Nicholas, et al.
Publicado: (2021)

EPEN-08. COMBINED PDGFR INHIBITOR AXITINIB AND RETINOID TRETINOIN DECREASES PROLIFERATION AND HIGH-RISK NEOPLASTIC SUBPOPULATION PROPORTIONS PFA EPENDYMOMA
por: Donson, Andrew, et al.
Publicado: (2023)

EPEN-16. Epithelial Progenitor Cell Abundance and Copy Number Variant Gains and Losses Impact the Biology of Recurrent Ependymoma
por: Norris, Gregory, et al.
Publicado: (2022)

EPEN-30. 5FU with Radiation Followed by Maintenance of 5FU and ATRA Significantly Improves Survival of 1q+/6q- PFA Ependymoma Xenograft Models
por: Grimaldo, Enrique, et al.
Publicado: (2022)

EPEN-23. A COMPUTATIONAL ANALYSIS OF THE TUMOUR IMMUNE MICROENVIRONMENT IN PAEDIATRIC EPENDYMOMA
por: Ritzmann, Timothy, et al.
Publicado: (2020)

EPEN-03. USP7 is an interaction partner of EZHIP and potential druggable target in PFA ependymomas
por: Jenseit, Anne, et al.
Publicado: (2022)

EPEN-26. Chemokine receptor blockade reverses CCL2 mediated immunosuppression and restores CAR-T cell function in posterior fossa ependymoma
por: Cole, Allison P, et al.
Publicado: (2022)

EPEN-05. Adenosine receptor expression in paediatric ependymoma
por: Spanoudakis, Chelsea, et al.
Publicado: (2022)

EPEN-07. A MULTICENTER STUDY OF POOR PROGNOSIS CHROMOSOME 1Q GAIN AND/OR 6Q LOSS IN POSTERIOR FOSSA A EPENDYMOMA SHOWS INCREASED PREVALENCE FROM 20% AT DIAGNOSIS TO 60% AT FIRST RECURRENCE
por: Donson, Andrew, et al.
Publicado: (2023)

EPEN-42. MOLECULAR PROFILING REVEALS DISTINCT SUBGROUPS OF PEDIATRIC SPINAL EPENDYMOMA
por: Ahmad, Omar, et al.
Publicado: (2020)

EPEN-01. MULTIDISCIPLINARY TREATMENT IN EPENDYMOMA
por: Hirokawa, Daisuke
Publicado: (2020)

EPEN-47. PEDS: PEDIATRIC EPENDYMOMA DISCOVERY STUDY
por: Smith, Amy, et al.
Publicado: (2020)

EPEN-24. SIOP EPENDYMOMA II: CENTRAL EPENDYMOMA MANAGEMENT ADVISORY GROUP – THE UK EXPERIENCE
por: Macarthur, Donald C, et al.
Publicado: (2020)

EPEN-20. PDL1 expression and tumor-infiltrating immune cell subpopulations: The role of immune-checkpoint molecules in the prognosis of patients with supratentorial ependymoma and its correlation to survival
por: Malik, Rafat, et al.
Publicado: (2022)

EPEN-43. TARGETING INTRA-TUMOUR HETEROGENEITY IN PAEDIATRIC EPENDYMOMA: AN INTEGRATED OMICS STUDY TOWARDS PATIENT-TAILORED THERAPY
por: Pandele, Alina, et al.
Publicado: (2020)

EPEN-16. TRANSCRIPTIONAL REGULATORY CIRCUITRIES AS MOLECULAR TARGETS IN EPENDYMOMA
por: Bertrand, Kelsey, et al.
Publicado: (2020)

EPEN-35. PERITONEAL CARCINOMATOSIS OF ANAPLASTIC EPENDYMOMA: FIRST REPORTED CASE
por: Schwartz, Jonathan, et al.
Publicado: (2020)

EPEN-52. METABOLIC REGULATION OF THE EPIGENOME DRIVES LETHAL INFANTILE EPENDYMOMA
por: Kumar, Sachin, et al.
Publicado: (2020)

EPEN-37. TREATMENT OUTCOME OF RECURRENT EPENDYMOMA IN CHILDREN IN NORTHERN EGYPT
por: Fadel, Shady, et al.
Publicado: (2020)

EPEN-45. NORMALIZING AND FACILITATING GENOMIC TESTING AT DIAGNOSIS IN PEDIATRIC EPENDYMOMA
por: Pickle, Emily Owens, et al.
Publicado: (2020)

EPEN-28. Oncogenic dependency of pediatric ependymomas on extracellular vesicle pathways
por: Maass, Kendra K, et al.
Publicado: (2022)

EPEN-31. Developmental and Oncogenic Transcription Factor Circuits as Dependencies in Ependymoma
por: Mack, Stephen
Publicado: (2022)

EPEN-51. CHILDHOOD INTRACRANIAL EPENDYMOMA: A MULTI-CENTER RETROSPECTIVE ANALYSIS
por: Pickle, Emily Owens, et al.
Publicado: (2020)

EPEN-32. Leveraging cell surface targets as therapeutic vulnerabilities for pediatric ependymoma
por: Bertrand, Kelsey
Publicado: (2022)

EPEN-25. A novel spontaneous model of ZFTA-RELA fusion ependymoma
por: Bell, Sigourney, et al.
Publicado: (2022)

EPEN-54. ACNS0831, PHASE III RANDOMIZED TRIAL OF POST-RADIATION CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED EPENDYMOMA AGES 1 TO 21 YEARS
por: Smith, Amy, et al.
Publicado: (2020)

EPEN-22. Molecularly aggressive ependymomas treated with Image guided pencil beam proton therapy: consecutive patient Indian experience
por: Sudarsan, Rishan Thimma, et al.
Publicado: (2022)

EPEN-06. CHEMOTHERAPY OF RECURRENT EPENDYMOMA: LONG-TERM RESPONSE ONLY IN FEW CASES
por: Adolph, Jonas, et al.
Publicado: (2020)

EPEN-04. Refinement of molecular and clinical characteristics in a cohort of 1,801 ependymomas
por: Pohl, Lara, et al.
Publicado: (2022)

EPEN-23. Interaction of epigenetic regulation and telomerase re-activation in high-risk ependymoma
por: Jaunecker, Carola N, et al.
Publicado: (2022)

EPEN-24. Biological markers of ependymoma in children and adolescents (BIOMECA): Systematic comparison of methods for the precise evaluation of biomarkers for ependymoma diagnosis and prognostication
por: Chapman, Rebecca, et al.
Publicado: (2022)

EPEN-18. CROSS-SPECIES GENOMICS IDENTIFIES GLI2 AS AN ONCOGENE OF C11orf95 FUSION-POSITIVE SUPRATENTORIAL EPENDYMOMA
por: Zheng, Tuyu, et al.
Publicado: (2020)

EPEN-07. PATTERNS OF EXTRANEURAL METASTASES IN PEDIATRIC SUPRATENTORIAL EPENDYMOMA: CASE SERIES AND REVIEW OF THE LITERATURE
por: Chan, Priya P, et al.
Publicado: (2020)

EPEN-46. DNA METHYLATION LANDSCAPE OF RECURRENT PEDIATRIC EPENDYMOMA IDENTIFIES KEY DRIVER EVENTS
por: Zhao, Sibo, et al.
Publicado: (2020)

EPEN-06. CELL ECOSYSTEM AND SIGNALING PATHWAYS OF PRIMARY AND METASTATIC PEDIATRIC POSTERIOR FOSSA EPENDYMOMA
por: Aubin, Rachael, et al.
Publicado: (2021)

EPEN-44. EXTRACELLULAR VESICLES OF SUPRATENTORIAL EPENDYMOMA RELA MEDIATE INTERACTIONS WITH CELLS OF THE TUMOR MICROENVIRONMENT
por: Maass, Kendra K, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dm7gibcn93v12terq5dkd665b0